Severe side effects (persistent vomiting, inability to eat) are rare with proper dosing but should be reported to your provider immediately
Lipid-based vehicles penetrate significantly better than water-based serums
Both tirzepatide and semaglutide have proven effective in clinical trials for promoting weight loss among patients with obesity, showcasing their potential as supporting treatments in weight management
identified that specific gut microbes inhibit remodeling-associated cytokines (IL-4, IL-5, IL-9, IL-13) through SCFA production, mitigating airway wall thickening ( Lactobacillus rhamnosus (Lr) administration reduced leukocyte infiltration, bronchial hyperreactivity, and remodeling markers (IL-4, IL-5, IL-13, STAT6, GATA3, IL-17, IL-21, IL-22, STAT3, RORt) in asthma-COPD overlap syndrome (Vasconcelos et al., 2023)
Commonly reported side effects include: Injection site reactions: Redness, irritation, or swelling at the injection site is the most frequent issue